Logo

ATGE

Adtalem Global Education Inc.

ATGE

Adtalem Global Education Inc. • NYSE
$92.56 ▲ 0.08% (+0.07)
Market Cap $3.36 B
52w High $156.26
52w Low $84.79
Dividend Yield 0%
P/E 14.15
Volume 255.03K
Outstanding Shares 36.33M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $462.288M ▲ $187.812M ▼ $61.062M ▲ 13.209% ▲ $1.69 ▲ $105.475M ▲
Q4-2025 $457.106M ▼ $194.441M ▲ $54.212M ▼ 11.86% ▼ $1.51 ▼ $99.889M ▼
Q3-2025 $466.055M ▲ $175.677M ▲ $60.832M ▼ 13.053% ▼ $1.64 ▼ $115.018M ▼
Q2-2025 $447.729M ▲ $157.223M ▼ $75.856M ▲ 16.942% ▲ $2.03 ▲ $124.029M ▲
Q1-2025 $417.4M $161.167M $46.165M 11.06% $1.22 $90.308M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $279.685M ▲ $2.867B ▲ $1.41B ▲ $1.458B ▲
Q4-2025 $213.964M ▼ $2.752B ▼ $1.319B ▼ $1.434B ▲
Q3-2025 $233.081M ▲ $2.79B ▲ $1.357B ▲ $1.433B ▼
Q2-2025 $208.219M ▼ $2.723B ▼ $1.284B ▼ $1.439B ▲
Q1-2025 $279.772M $2.818B $1.428B $1.39B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $61.062M ▲ $130.549M ▲ $-16.023M ▼ $-49.505M ▲ $65.021M ▲ $114.526M ▲
Q4-2025 $54.462M ▼ $59.692M ▼ $-11.656M ▼ $-68.053M ▲ $-20.017M ▼ $40.702M ▼
Q3-2025 $60.794M ▼ $207.91M ▲ $-10.049M ▲ $-172.099M ▼ $25.762M ▲ $197.667M ▲
Q2-2025 $71.176M ▲ $-19.019M ▼ $-10.681M ▼ $-41.753M ▼ $-71.453M ▼ $-29.699M ▼
Q1-2025 $46.245M $89.316M $-9.535M $-34.111M $45.67M $78.902M

Revenue by Products

Product Q2-2025Q3-2025Q4-2025Q1-2026
Chamberlain
Chamberlain
 $180.00M ▲$190.00M ▲$180.00M ▼$180.00M ▲
Medical and Veterinary
Medical and Veterinary
 $100.00M ▲$100.00M ▲$90.00M ▼$90.00M ▲
Walden University
Walden University
 $170.00M ▲$180.00M ▲$180.00M ▲$190.00M ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has been climbing steadily over the past several years, and profits have generally followed in the same direction. Margins look healthier than they used to, suggesting better cost control and operating efficiency. That said, net income and earnings per share have been somewhat bumpy, with at least one year that appears affected by unusual items or restructuring. Overall, the trend is toward a more profitable business, but the past volatility reminds us that results can swing when there are big strategic or accounting changes.

Balance Sheet

Balance Sheet The balance sheet looks more streamlined than it did a few years ago. Total assets have been fairly stable, while debt has been coming down, which reduces financial risk and interest pressure. Equity has edged up, pointing to gradual strengthening of the company’s capital base. Cash on hand is lower than it was several years ago, so there is less of a cash cushion, but the reduced debt load partly offsets that concern. In simple terms, the company appears to be slowly trading a more leveraged profile for a more balanced, less risky one.

Cash Flow

Cash Flow Cash generation from the core business has improved meaningfully. Operating cash flow has grown over time, and free cash flow has generally been positive, with only a brief soft patch earlier in the period. Investment in physical assets has been modest and consistent, which helps keep free cash flow healthy. The pattern suggests a business that is increasingly converting its earnings into cash, giving management more flexibility for debt reduction, investment in growth initiatives, or shareholder-focused uses, depending on strategy and constraints.

Competitive Edge

Competitive Edge Adtalem operates in a niche that combines education with healthcare, a field supported by ongoing shortages of nurses and other medical professionals. Its scale in nursing and medical education, along with well-known brands like Chamberlain and Walden, gives it name recognition with both students and employers. The company’s focus on program quality, licensure outcomes, and job placement helps differentiate it from more generalized for-profit education providers. Strong relationships with healthcare systems and its role as a major source of graduates create a feedback loop: employers rely on Adtalem for talent, and students are attracted by those employment outcomes. The main risks center on regulatory scrutiny of for-profit education, competition from traditional universities expanding online, and the need to keep student outcomes strong as the company grows.

Innovation and R&D

Innovation and R&D The company is leaning heavily into technology, especially artificial intelligence, to reshape its offerings. Its AI tutor, partnerships with Hippocratic AI, and collaboration with Google Cloud for AI-focused healthcare credentials all point to a strategy of being early in the adoption of AI in medical education. The “Practice Ready. Specialty Focused.” model and specialty partnerships, such as in oncology nursing, show a push toward more tailored and practice-oriented training. These initiatives could deepen its competitive moat if they improve student success and employer satisfaction, and they may open new revenue streams in AI literacy for clinicians. The flip side is execution risk: integrating AI responsibly, ensuring regulatory and ethical compliance, and proving that these innovations truly enhance learning and clinical outcomes will all be critical.

Summary

Adtalem today looks like a more focused and financially stronger healthcare education company than it was a few years ago. Revenue and operating profits have been trending upward, cash flow has improved, and the balance sheet has become less debt-heavy, all of which point to a more durable business model. Strategically, the company is betting on two big themes: sustained demand for healthcare professionals and the rise of AI in clinical practice and education. Its scale, brand recognition in nursing and medical education, and deep ties to healthcare employers provide meaningful advantages. Key watch points include regulatory developments in for-profit education, the real-world impact of its AI initiatives, the ability to keep enrollment and student outcomes strong, and the discipline with which management balances growth investments against financial stability.

NEWS

November 5, 2025 · 6:00 AM UTC

Adtalem Accelerates $150 Million Share Repurchase Program

Read more

October 31, 2025 · 3:38 PM UTC

Adtalem Global Education Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ATGE

Read more

October 30, 2025 · 4:15 PM UTC

Adtalem Global Education First Quarter Fiscal Year 2026 Results; Maintains Fiscal Year 2026 Guidance

Read more

October 23, 2025 · 8:00 AM UTC

Adtalem Global Education Expands Pathways to Medical School

Read more

October 15, 2025 · 5:00 PM UTC

Adtalem Global Education and Google Cloud Partner to Launch New AI Credentials Program for Healthcare Professionals

Read more